Romidepsin–CHOEP Followed by High-Dose Chemotherapy and ASCT for Untreated Peripheral T-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
Leukemia 2023 Jan 18;[EPub Ahead of Print], A Chiappella, A Dodero, A Evangelista, A Re, L Orsucci, SV Usai, C Castellino, V Stefoni, A Pinto, M Zanni, R Ciancia, C Ghiggi, FG Rossi, A Arcari, F Ilariucci, VR Zilioli, L Flenghi, M Celli, S Volpetti, F Benedetti, F Ballerini, G Musuraca, R Bruna, C Patti, F Leonardi, L Arcaini, M Magagnoli, F Cavallo, A Bermema, A Tucci, C Boccomini, G Ciccone, C Carniti, SA Pileri, P CorradiniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.